Chronic Administration of Cannabinoid Receptor 2 Agonist (JWH-133) Increases Ectopic Ovarian Tumor Growth and Endocannabinoids (Anandamide and 2-Arachidonoyl Glycerol) Levels in Immunocompromised SCID Female Mice

Cannabinoid-based therapies are increasingly being used by cancer patients to treat chemotherapy-induced nausea and vomiting. Recently, cannabinoids have gained increased attention for their effects on cancer growth. Indeed, the effect of CB(2) (JWH-015, JWH-133) agonists on breast cancer models hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Blanton, Henry L., McHann, Melissa C., De Selle, Haley, Dancel, Canice Lei, Redondo, Jose-Luis, Molehin, Deborah, German, Nadezhda A., Trasti, Scott, Pruitt, Kevin, Castro-Piedras, Isabel, Guindon, Josée
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886292/
https://www.ncbi.nlm.nih.gov/pubmed/35242036
http://dx.doi.org/10.3389/fphar.2022.823132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886292/
https://www.ncbi.nlm.nih.gov/pubmed/35242036
http://dx.doi.org/10.3389/fphar.2022.823132

Ejemplares similares